- Home
- RLMD vs GELS Comparison
RLMD vs GELS Comparison
Compare RLMD & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- GELS
- Stock Information
- Founded
- RLMD 2004
- GELS 2018
- Country
- RLMD United States
- GELS Australia
- Employees
- RLMD N/A
- GELS N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- RLMD Health Care
- GELS
- Exchange
- RLMD Nasdaq
- GELS NYSE
- Market Cap
- RLMD 11.5M
- GELS 12.6M
- IPO Year
- RLMD N/A
- GELS 2024
- Fundamental
- Price
- RLMD $0.30
- GELS $1.01
- Analyst Decision
- RLMD Hold
- GELS
- Analyst Count
- RLMD 4
- GELS 0
- Target Price
- RLMD $4.25
- GELS N/A
- AVG Volume (30 Days)
- RLMD 382.7K
- GELS 29.2K
- Earning Date
- RLMD 03-27-2025
- GELS 02-15-2025
- Dividend Yield
- RLMD N/A
- GELS N/A
- EPS Growth
- RLMD N/A
- GELS N/A
- EPS
- RLMD N/A
- GELS N/A
- Revenue
- RLMD N/A
- GELS $95,618.00
- Revenue This Year
- RLMD N/A
- GELS N/A
- Revenue Next Year
- RLMD N/A
- GELS N/A
- P/E Ratio
- RLMD N/A
- GELS N/A
- Revenue Growth
- RLMD N/A
- GELS N/A
- 52 Week Low
- RLMD $0.24
- GELS $0.90
- 52 Week High
- RLMD $5.09
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- RLMD 50.05
- GELS N/A
- Support Level
- RLMD $0.26
- GELS N/A
- Resistance Level
- RLMD $0.32
- GELS N/A
- Average True Range (ATR)
- RLMD 0.02
- GELS 0.00
- MACD
- RLMD 0.00
- GELS 0.00
- Stochastic Oscillator
- RLMD 67.34
- GELS 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.